Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. reports on a Board of Directors meeting held on May 16, 2017, in Buenos Aires, Argentina. The filing details corporate governance actions, including the election of Co-Chairmen, the approval of an extraordinary balance sheet as of April 30, 2017, and the authorization of specific financial instruments.
Key Financial Metrics and Capital Actions
- Dividend Declaration: The Board approved a dividend of R$ 0.16 per share, to be deducted from 2017 fiscal year results and attributed to minimum mandatory dividends.
- Payment Schedule: Payment is scheduled for July 17, 2017, subject to shareholder approval. The record date is June 23, 2017 (BM&FBovespa) and June 28, 2017 (NYSE), with shares trading ex-dividend from June 26, 2017.
- Share Capital: There are 4,356,507,885 outstanding shares. The Company holds 11,677,352 shares in treasury.
- Equity Swap Authorization: The Board approved equity swap agreements with a maximum exposure of 80 million common shares (or ADRs) and a limit value of up to R$ 1.5 billion.
Material Changes and Corporate Actions
- Leadership: Victorio Carlos De Marchi and Carlos Alves de Brito were elected as Co-Chairmen of the Board following the Annual Shareholders' Meeting on April 28, 2017.
- Financial Instrument: The Company authorized equity swaps to hedge against stock price volatility related to share-based payment programs. These are financially settled derivatives with a maximum term of 18 months.
- Balance Sheet: An extraordinary balance sheet was prepared as of April 30, 2017, to support the dividend distribution.
Outlook, Risks, and Management Commentary
Purpose of Equity Swaps: Management stated the swaps are intended to neutralize the effects of stock price oscillations on share-based compensation costs. The Board confirmed the Company's current financial situation is compatible with these operations and will not affect obligations to creditors or mandatory dividend payments.
Risks and Contingencies:
- Counterparties may terminate agreements if the share price depreciates by 50% or more.
- The Company retains the option to terminate contracts at any time at its sole discretion.
- Counterparties will not be related parties.
Missing Data: The filing text does not provide specific values for revenue, net profit, operating cash flow, margins, total debt, or liquidity ratios for the period ending June 30, 2017, as this document focuses on Board resolutions rather than full financial statements.
Investor Verification Checklist
- Verify the final approval of the R$ 0.16 per share dividend at the Annual Shareholders' Meeting.
- Confirm the execution details and specific counterparties for the authorized R$ 1.5 billion equity swap program.
- Monitor the impact of the equity swaps on the Company's financial statements in subsequent quarterly reports.
- Review the full extraordinary balance sheet dated April 30, 2017, for detailed asset and liability positions.